Screener
Fulgent Genetics, Inc. FLGT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Repayment of notes payable | (476) | (470) |
| Principal paid for finance lease | (88) | (136) |
| Proceeds from exercise of stock options | 9 | — |
| Net cash used in financing activities | (44,833) | (11,172) |
| Effect of exchange rate changes on cash and cash equivalents | 3 | 11 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (26,794) | 12,137 |
| Cash, cash equivalents, and restricted cash at beginning of period | 50,328 | 55,279 |
| Cash, cash equivalents, and restricted cash at end of period | $23,534 | $67,416 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s financing cash flow?
- Fulgent Genetics, Inc. (FLGT) reported financing cash flow of -$44.83M in Q1 2026.
- How has Fulgent Genetics, Inc.'s financing cash flow changed year-over-year?
- Fulgent Genetics, Inc.'s financing cash flow decreased by 301.3% year-over-year, from -$11.17M to -$44.83M.
- What is the long-term trend for Fulgent Genetics, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s financing cash flow has grown at a -36.0% compound annual growth rate (CAGR), from $88.39M to -$14.79M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Fulgent Genetics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude